openFDA 药品召回·· 7 天前精选AI 评分58
费森尤斯医疗召回DELFLEX腹膜透析液,因主袋穿孔渗漏缺乏无菌保证
DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25321. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-94
AI 导读
费森尤斯医疗(Fresenius Medical Care)召回DELFLEX腹膜透析液(含1.5%葡萄糖、低镁/低钙,附stay safe交换装置,2,500 mL单剂量袋,NDC 46163-206-94),召回编号D-0169-2027。召回原因为缺乏无菌保证:已收到相关投诉,涉及受影响批次主袋印刷区小穿孔可能导致渗漏。
推荐理由
召回原因指向主袋印刷区小穿孔可能导致渗漏,读者可了解无菌保障缺失的具体来源。
来源:openFDA 药品召回 · api.fda.gov